Filtered By:
Specialty: Drugs & Pharmacology
Condition: Hemorrhagic Stroke
This page shows you your search results in order of relevance. This is page number 7.
Order by Relevance | Date
Total 692 results found since Jan 2013.
Effect of intravenous thrombolysis in acute ischemic stroke patients with cerebral microbleeds and analysis of risk factors for hemorrhagic transformation
CONCLUSIONS: Compared with those undergoing no intravenous thrombolysis with rt-PA, patients with acute ischemic stroke and CMB who received intravenous thrombolysis with rt-PA exhibit significantly improved short-term neurological function recovery and long-term prognosis, but the incidence and mortality rates of ICH have no statistically significant differences. Moreover, the time from stroke onset to thrombolysis, baseline NIHSS score, and history of atrial fibrillation are independent risk factors affecting the HT of patients treated with intravenous thrombolysis.PMID:35179744 | DOI:10.26355/eurrev_202202_27986
Source: European Review for Medical and Pharmacological Sciences - February 18, 2022 Category: Drugs & Pharmacology Authors: Y-S Lei H Li J-Y Lei S-X Li D-F Li Source Type: research
Lumbrokinase regulates endoplasmic reticulum stress to improve neurological deficits in ischemic stroke
In this study, we aimed to clarify the neuroprotection of lumbrokinase in mice subjected to permanent middle cerebral artery occlusion. Lumbrokinase significantly attenuated infarct volume and improved neurological dysfunction. Lumbrokinase dramatically decreased the expressions of the endoplasmic reticulum (ER) transmembrane receptor protein inositol-requiring enzyme-1 (IRE1) and its downstream transcription factor, XBP-1, caspase-12, and NF-κB activity, thereby significantly inhibiting apoptosis and autophagy and decreasing the NLRP3 inflammasome. Our evidence indicates that post-stroke treatment with lumbrokinase prote...
Source: Neuropharmacology - October 12, 2022 Category: Drugs & Pharmacology Authors: Yi-Hsin Wang Jiuan-Miaw Liao Ke-Min Chen Hsing-Hui Su Pei-Hsun Liu Yi-Hung Chen Yuang-Seng Tsuei Chin-Feng Tsai Shiang-Suo Huang Source Type: research
Tirofiban in the treatment of cancer-associated ischemic stroke
CONCLUSIONS: Early administration of tirofiban in the treatment of mild to moderate ischemic stroke is safe, which can reduce 24-hour and 7-day NIHSS scores and has potential value.PMID:37140310 | DOI:10.26355/eurrev_202304_32142
Source: Pharmacological Reviews - May 4, 2023 Category: Drugs & Pharmacology Authors: Z-M Zhang Z-H Lin G-L Zhu Source Type: research
